Valeriia R. Rodichkina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Valeriia R. Rodichkina has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Igor Moiseyevich Kvetnoy
Saint-Petersburg State University, Saint-Petersburg, Russia;Saint-Petersburg Research Institute of Phthisiopulmonology, Saint-Petersburg, Russia, Russia
4 shared publications - Anna Olegovna Drobintseva
Saint Petersburg State Pediatric Medical University
3 shared publications - Dmitry O. Ivanov
Санкт-Петербургский государственный педиатрический медицинский университет
2 shared publications - Ekaterina Mironova
Saint Petersburg Institute of Bioregulation and Gerontology, 197110 Saint Petersburg, Russia
2 shared publications - Igor Yurievich Kogan
D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, 199034 St. Petersburg, Russia
2 shared publications - Ruslan Abdullayevich Nasyrov
Saint Petersburg State Pediatric Medical University
2 shared publications
Latest Publications
- Open Access
- 2 September 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (9) , 1987
Inflammaging: Expansion of Molecular Phenotype and Role in Age-Associated Female Infertility
Cellular aging is considered as one of the main factors implicated in female infertility. We evaluated the expression of senescence-associated secretory phenotype (SASP) markers and additional molecular factors in an in vitro model of cellular aging. We induced genotoxic stress (UVB/UVA ray irradiation) in primary human endometrial cells obtained from female subjects of young reproductive age (<35 years of age). We assessed the expression levels of IL-6, IL-8, IL-1α, MMP3, SIRT-1, SIRT-6, TERF-1, and CALR at the mRNA level by RT-qPCR and at the protein level by immunofluorescence and confocal microscopy in primary human endometrial cells upon induction of genotoxic stress and compared them to untreated cells. Statistically significant differences were found for the expression of SIRT-1, SIRT-6, and TERF, which were found to be decreased upon induction of cell senescence through genotoxic stress, while IL-6, IL-8, IL-1α, MMP3, and p16 were found to be increased in senescent cells. We propose that these molecules, in addition to SAS-linked factors, could represent novel markers, and eventually potential therapeutic targets, for the aging-associated dysfunction of the female reproductive system.
- 2 September 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (9) , 1987
Open AccessInflammaging: Expansion of Molecular Phenotype and Role in Age-Associated Female Infertility
Cellular aging is considered as one of the main factors implicated in female infertility. We evaluated the expression of senescence-associated secretory phenotype (SASP) markers and additional molecular factors in an in vitro model of cellular aging. We induced genotoxic stress (UVB/UVA ray irradiation) in primary human endometrial cells obtained from female subjects of young reproductive age (<35 years of age). We assessed the expression levels of IL-6, IL-8, IL-1α, MMP3, SIRT-1, SIRT-6, TERF-1, and CALR at the mRNA level by RT-qPCR and at the protein level by immunofluorescence and confocal microscopy in primary human endometrial cells upon induction of genotoxic stress and compared them to untreated cells. Statistically significant differences were found for the expression of SIRT-1, SIRT-6, and TERF, which were found to be decreased upon induction of cell senescence through genotoxic stress, while IL-6, IL-8, IL-1α, MMP3, and p16 were found to be increased in senescent cells. We propose that these molecules, in addition to SAS-linked factors, could represent novel markers, and eventually potential therapeutic targets, for the aging-associated dysfunction of the female reproductive system.
- Open Access
- 9 April 2024
- Published by MDPI AG in Preprints.org
Inflammaging: Expanding the Molecular Palette of Cellular Immunophenotype
Cellular aging is considered as one of the main factors leading to female infertility. The process called “inflammaging”, which was proposed by C. Franceschi in 2014 is characterized by chronic asymptomatic inflammation state resulting to whole body aging and age-associated diseases. In this work the inflammaging model was developed; markers expression associated with SASP (senescence associated secretory phenotype) and cell aging were verified in endometrial cells; the correlation analysis with the known inflammaging markers was done; as well as the age dynamic of markers expression in the groups of young reproductive age and late reproductive age was evaluated. For the first time, the comparative study of the expression of the key signalling molecules involved in the mechanisms of the aging was carried out: IL-6, IL-8, IL-1a, MMP3, SIRT1,6, TERF-1, CALR in endometrial cells in the age aspect and under the influence of the genotoxic stress. The SASP phenotype characterizing the phenomenon of inflammaging can be significantly expanded by the including of the studied molecules - SIRT-1, SIRT-6, TERF, CALR, that we demonstrated for the first time. These signalling molecules may be new therapeutic targets for the age-associated female reproductive system diseases treatment.
- 9 April 2024
- Published by MDPI AG in Preprints.org
Open AccessInflammaging: Expanding the Molecular Palette of Cellular Immunophenotype
Cellular aging is considered as one of the main factors leading to female infertility. The process called “inflammaging”, which was proposed by C. Franceschi in 2014 is characterized by chronic asymptomatic inflammation state resulting to whole body aging and age-associated diseases. In this work the inflammaging model was developed; markers expression associated with SASP (senescence associated secretory phenotype) and cell aging were verified in endometrial cells; the correlation analysis with the known inflammaging markers was done; as well as the age dynamic of markers expression in the groups of young reproductive age and late reproductive age was evaluated. For the first time, the comparative study of the expression of the key signalling molecules involved in the mechanisms of the aging was carried out: IL-6, IL-8, IL-1a, MMP3, SIRT1,6, TERF-1, CALR in endometrial cells in the age aspect and under the influence of the genotoxic stress. The SASP phenotype characterizing the phenomenon of inflammaging can be significantly expanded by the including of the studied molecules - SIRT-1, SIRT-6, TERF, CALR, that we demonstrated for the first time. These signalling molecules may be new therapeutic targets for the age-associated female reproductive system diseases treatment.
- 1 May 2019
- Published by Russian Vrach, Publishing House Ltd. in Молекулярная медицина
- Vol. 17 (3)
INFLAMAGING: MOLECULAR-CELLULAR MECHANISMS OF FEMALE REPRODUCTIVE SYSTEM AGING
- 1 May 2019
- Published by Russian Vrach, Publishing House Ltd. in Молекулярная медицина
- Vol. 17 (3)
INFLAMAGING: MOLECULAR-CELLULAR MECHANISMS OF FEMALE REPRODUCTIVE SYSTEM AGING
- Open Access
- 15 June 2018
- Published by ECO-Vector LLC in Journal of obstetrics and women's diseases
- Vol. 67 (2) , 61-69
Ovarian aromatase activity: evaluation methods and the clinical significance in IVF protocols
Introduction. Cytochrome P450 aromatase is a key enzyme in the biosynthesis of estrogens from androgens. Some gynecological diseases are accompanied with changes in the activity of ovarian aromatase. Moreover, changes in the acti vity of ovarian aromatase are associated with the response to standard gonadotrophin stimulation in women undergoing in vitro fertilization. A new effective method determining the activity of ovarian aromatase without using ovarian tissue biopsy has been developed. The purpose of the present study was to compare the detection of ovarian aromatase activity using the ratio of estradiol to AMH on the second day of the menstrual cycle through the immunocytochemical evaluation of aromatase expression in cumulus cells. Methods. Depending on the activity of the ovarian aromatase, calculated on the second day of the menstrual cycle, 16 patients undergoing IVF protocols were categorized into three groups: eight patients with low activity, four with normal activity, and four with high activity. The patients did not differ in age and BMI. The expression of aromatase in cumulus cells obtained through transvaginal puncture was investigated by the immunocytochemical method. Results. The fluorescence intensities in the low, normal, and high activity groups were 134 (122–161), 238 (201–251), and 259 (240–299), respectively. Differences between these groups were statistically significant (p = 0.008). There was a pronounced positive correlation between the activity of ovarian aromatase, calculated on day two of the menstrual cycle, and the intensity of aromatase fluorescence in cumulus cells (Spearman, r = 0.75, p = 0.001, n = 16).
- 15 June 2018
- Published by ECO-Vector LLC in Journal of obstetrics and women's diseases
- Vol. 67 (2) , 61-69
Open AccessOvarian aromatase activity: evaluation methods and the clinical significance in IVF protocols
Introduction. Cytochrome P450 aromatase is a key enzyme in the biosynthesis of estrogens from androgens. Some gynecological diseases are accompanied with changes in the activity of ovarian aromatase. Moreover, changes in the acti vity of ovarian aromatase are associated with the response to standard gonadotrophin stimulation in women undergoing in vitro fertilization. A new effective method determining the activity of ovarian aromatase without using ovarian tissue biopsy has been developed. The purpose of the present study was to compare the detection of ovarian aromatase activity using the ratio of estradiol to AMH on the second day of the menstrual cycle through the immunocytochemical evaluation of aromatase expression in cumulus cells. Methods. Depending on the activity of the ovarian aromatase, calculated on the second day of the menstrual cycle, 16 patients undergoing IVF protocols were categorized into three groups: eight patients with low activity, four with normal activity, and four with high activity. The patients did not differ in age and BMI. The expression of aromatase in cumulus cells obtained through transvaginal puncture was investigated by the immunocytochemical method. Results. The fluorescence intensities in the low, normal, and high activity groups were 134 (122–161), 238 (201–251), and 259 (240–299), respectively. Differences between these groups were statistically significant (p = 0.008). There was a pronounced positive correlation between the activity of ovarian aromatase, calculated on day two of the menstrual cycle, and the intensity of aromatase fluorescence in cumulus cells (Spearman, r = 0.75, p = 0.001, n = 16).
- Open Access
- 15 June 2017
- Published by ECO-Vector LLC in Journal of obstetrics and women's diseases
- Vol. 66 (3) , 8-15
New approaches to the estimation of endometrial dysfunction
Introduction. The application of modern methods for assessing the morphofunctional state of the endometrium to verify and study the expression of sex steroid hormones, proinflammatory markers and markers of angiogenesis using confocal laser scanning microscopy will allow an objective study of the role of studied markers in the pathogenesis of the endometrial dysfunction. The aim of the study was to evaluate the expression of ER and PR receptors in endometrium in patients with endometrial dysfunction. Material and methods. Endometrial biopsy specimens obtained with the aid of a pile-biopsy or a scraping from the uterine cavity are used to conduct the method of immunofluorescent confocal laser scanning microscopy. It is possible to use both cryostat material and paraffin blocks to provide the immunohistochemical analysis. Monoclonal antibodies to ER (1 : 60, Dako, Denmark) and PR (1 : 50, Dako, Denmark) are used as primary antibodies, antibodies conjugated with fluorochrome Alexa Fluor 647 (1 : 1000, Abcam, England) are used as secondary antibodies). Hoechst 33258 (Sigma, USA) is used for staining of cell nuclei. Results. A method of confocal laser scanning microscopy makes it possible to conduct qualitative and quantitative evaluation of the studied markers in different structures of the endometrium. (For citation: Journal of Obstetrics and Women’s Diseases. 2017;66(3):8-15. doi: 10.17816/JOWD6638-15).
- 15 June 2017
- Published by ECO-Vector LLC in Journal of obstetrics and women's diseases
- Vol. 66 (3) , 8-15
Open AccessNew approaches to the estimation of endometrial dysfunction
Introduction. The application of modern methods for assessing the morphofunctional state of the endometrium to verify and study the expression of sex steroid hormones, proinflammatory markers and markers of angiogenesis using confocal laser scanning microscopy will allow an objective study of the role of studied markers in the pathogenesis of the endometrial dysfunction. The aim of the study was to evaluate the expression of ER and PR receptors in endometrium in patients with endometrial dysfunction. Material and methods. Endometrial biopsy specimens obtained with the aid of a pile-biopsy or a scraping from the uterine cavity are used to conduct the method of immunofluorescent confocal laser scanning microscopy. It is possible to use both cryostat material and paraffin blocks to provide the immunohistochemical analysis. Monoclonal antibodies to ER (1 : 60, Dako, Denmark) and PR (1 : 50, Dako, Denmark) are used as primary antibodies, antibodies conjugated with fluorochrome Alexa Fluor 647 (1 : 1000, Abcam, England) are used as secondary antibodies). Hoechst 33258 (Sigma, USA) is used for staining of cell nuclei. Results. A method of confocal laser scanning microscopy makes it possible to conduct qualitative and quantitative evaluation of the studied markers in different structures of the endometrium. (For citation: Journal of Obstetrics and Women’s Diseases. 2017;66(3):8-15. doi: 10.17816/JOWD6638-15).
- 1 May 2017
- Published by Pleiades Publishing Ltd in Russian Journal of Developmental Biology
- Vol. 48 (3) , 169-175
Immunohistochemical verification of kisspeptins and their receptor in human fetal organs during prenatal development
Kisspeptins (KPs) and their receptor (KISS1R) play an important role in many physiological processes in the body, such as sexual maturation, reproductive system functioning, placentation, insulin secretion, and vasoconstriction. The highest level of kisspeptins and their receptor is observed in the organs of hypothalamic-pituitary-gonadal and hypothalamic-pituitary-adrenal axes, both in the form of mRNA and peptide. Kisspeptins are found in various body tissues: spinal cord (Dun et al., 2003), pancreas (Song et al., 2014), esophagus (Kostakis et al., 2013), adrenal glands and secretory system organs (Wahab et al., 2015), and in malignancies (Lee and Welch, 1997). However, the localization and the role of kisspeptins and their receptor in organs during fetal development have not yet been studied. At the same time, ample published data regarding the localization of kisspeptins and their receptors in human organs and tissues are discrepant, which requires the development of a standard staining technique. The modified technique presented in this paper made it possible to identify and evaluate the expression of kisspeptins and their receptor in human fetal organs at different stages of development. Kisspeptins and their receptors were found in all organs and tissues examined by us, but the degree of reaction was different. The highest level was observed in the hypothalamus material in the 28–32-week period, and the lowest amount of the protein was detected in the uterine material at all stages. Maximum level of KISS1R was detected in the pituitary material in the 36–40-week period. A correlation between gestational age and the level of kisspeptins in the ovaries, uterus, and adrenal glands was found: a significant increase in the amount of protein was detected. A significant increase in the amount of the kisspeptin receptor in pituitary, ovary, and uterus material was shown.
- 1 May 2017
- Published by Pleiades Publishing Ltd in Russian Journal of Developmental Biology
- Vol. 48 (3) , 169-175
Immunohistochemical verification of kisspeptins and their receptor in human fetal organs during prenatal development
Kisspeptins (KPs) and their receptor (KISS1R) play an important role in many physiological processes in the body, such as sexual maturation, reproductive system functioning, placentation, insulin secretion, and vasoconstriction. The highest level of kisspeptins and their receptor is observed in the organs of hypothalamic-pituitary-gonadal and hypothalamic-pituitary-adrenal axes, both in the form of mRNA and peptide. Kisspeptins are found in various body tissues: spinal cord (Dun et al., 2003), pancreas (Song et al., 2014), esophagus (Kostakis et al., 2013), adrenal glands and secretory system organs (Wahab et al., 2015), and in malignancies (Lee and Welch, 1997). However, the localization and the role of kisspeptins and their receptor in organs during fetal development have not yet been studied. At the same time, ample published data regarding the localization of kisspeptins and their receptors in human organs and tissues are discrepant, which requires the development of a standard staining technique. The modified technique presented in this paper made it possible to identify and evaluate the expression of kisspeptins and their receptor in human fetal organs at different stages of development. Kisspeptins and their receptors were found in all organs and tissues examined by us, but the degree of reaction was different. The highest level was observed in the hypothalamus material in the 28–32-week period, and the lowest amount of the protein was detected in the uterine material at all stages. Maximum level of KISS1R was detected in the pituitary material in the 36–40-week period. A correlation between gestational age and the level of kisspeptins in the ovaries, uterus, and adrenal glands was found: a significant increase in the amount of protein was detected. A significant increase in the amount of the kisspeptin receptor in pituitary, ovary, and uterus material was shown.